Time trends in incidence and prognosis of primary liver cancer and liver metastases of unknown origin in a Danish region, 1985-2004

European Journal of Gastroenterology and Hepatology

Volumn 20, Issue 2, 2008, Pages 104-110

  Erichsen, Rune ^a,b   Jepsen, Peter ^a   Jacobsen, Jacob ^a   Nørgaard, Mette ^a   Vilstrup, Hendrik ^a   Sørensen, Henrik T ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Incidence; Liver metastasis; Primary liver cancer; Prognosis; Unknown primary neoplasm

Indexed keywords

ARTICLE; CANCER INCIDENCE; CANCER SURVIVAL; COMORBIDITY; DENMARK; DISEASE COURSE; HUMAN; LIVER CANCER; LIVER METASTASIS; POPULATION RESEARCH; PRIORITY JOURNAL; PROGNOSIS; TREND STUDY;

ADOLESCENT; ADULT; AGED; DENMARK; FEMALE; HUMANS; INCIDENCE; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASMS, UNKNOWN PRIMARY; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 38049160169     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e3282f17517     Document Type: Article

References (33)

1. Hansen NE, Haunsø S, Schaffalizky De Muckadell OB. Medicinsk Kompendium. Nyt Nordisk Forlag Arnold Busk 2004; 16:1696-1699.
2. Sherman M. Screening for hepatocellular carcinoma. Best Pract Res Clin Gastroenterol 2005; 19:101-118.
3. Sherman M. Hepatocellular carcinoma: epidemiology, risk factors, and screening. Semin Liver Dis 2005; 25:143-154.
4. Befeler AS, Di Bisceglie AM. Hepatocellular carcinoma: diagnosis and treatment. Gastroenterology 2002; 122:1609-1619.
5. Coakley FV, Schwartz LH. Imaging of hepatocellular carcinoma: a practical approach. Semin Oncol 2001; 28:460-473.
6. Taura N, Hamasaki K, Nakao K, Ichikawa T, Nishimura D, Goto T, et al. The impact of newer treatment modalities on survival in patients with hepatocellular carcinoma. Clin Gastroenterol Hepatol 2006; 4:1177-1183.
7. Andriulli A, de Sio I, Solmi L, De Carlis L, Troisi R, Grasso A, et al. Survival of cirrhotic patients with early hepatocellular carcinoma treated by percutaneous ethanol injection or liver transplantation. Liver Transpl 2004; 10:1355-1363.
8. Farinati F, Gianni S, Marin G, Fagiuoli S, Rinaldi M, Naccarato R. Does the choice of treatment influence survival of patients with small hepatocellular carcinoma in compensated cirrhosis? Eur J Gastroenterol Hepatol 2001; 13:1217-1224.
9. Colella G, Bottelli R, De CL, Sansalone CV, Rondinara GF, Alberti A, et al. Hepatocellular carcinoma: comparison between liver transplantation, resective surgery, ethanol injection, and chemoembolization. Transpl Int 1998; 11:S193-S196.
10. Llovet JM, Sala M. Non-surgical therapies of hepatocellular carcinoma. Eur J Gastroenterol Hepatol 2005; 17:505-513.
11. Markovic S, Gadzijev E, Stabuc B, Croce LS, Masutti F, Surlan M, et al. Treatment options in Western hepatocellular carcinoma: a prospective study of 224 patients. J Hepatol 1998; 29:650-659.
12. Hawksworth J, Geisinger K, Zagoria R, Kavanagh P, Howerton R, Levine EA, et al. Surgical and ablative treatment for metastatic adenocarcinoma to the liver from unknown primary tumor. Am Surg 2004; 70:512-517.
13. Zoepf T, Jakobs R, Arnold JC, Apel D, Riemann JF. Palliation of nonresectable bile duct cancer: improved survival after photodynamic therapy. Am J Gastroenterol 2005; 100:2426-2430.
14. Frank L. Epidemiology. When an entire country is a cohort. Science 2000; 287:2398-2399.
15. Almdal TP, Sorensen TI. Incidence of parenchymal liver diseases in Denmark, 1981 to 1985: analysis of hospitalization registry data. The Danish Association for the Study of the Liver. Hepatology 1991; 13:650-655.
16. Danish National Board of Health. 8th revision of the World Health Organisations classification of diseases. Copenhagen: National Board of Health; 1986.
17. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40:373-383.
18. Bosch FX, Ribes J, Diaz M, Cleries R. Primary liver cancer: worldwide incidence and trends. Gastroenterology 2004; 127:S5-S16.
19. Gaiani S, Volpe L, Piscaglia F, Bolondi L. Vascularity of liver tumours and recent advances in doppler ultrasound. J Hepatol 2001; 34:474-482.
20. Saini S. Imaging of the hepatobiliary tract. N Engl J Med 1997; 336:1889-1894.
21. Harvey CJ, Lim AK, Blomley MJ, Taylor-Robinson SD, Gedroyc WM, Cosgrove DO. Detection of an occult hepatocellular carcinoma using ultrasound with liver-specific microbubbles. Eur Radiol 2002; 12:S70-S73.
22. Keiding S. Functional imaging of the liver with positron emission tomography. Danish Society of Hepatology. Ugeskr Laeger 2005; 167:1390.
23. Jepsen P, Vilstrup H, Tarone RE, Friis S, Sørensen HT. Incidence rates of hepatocellular carcinomas in the US and Denmark: recent trends. Int J Cancer 2007; 121:1624-1626.
24. Van de Wouw AJ, Janssen-Heijnen ML, Coebergh JW, Hillen HF. Epidemiology of unknown primary tumours; incidence and population-based survival of 1285 patients in Southeast Netherlands, 1984-1992. Eur J Cancer 2002; 38:409-413.
25. Levi F, Te VC, Erler G, Randimbison L, La VC. Epidemiology of unknown primary tumours. Eur J Cancer 2002; 38:1810-1812.
26. Mant JW, Vessey MP. Trends in mortality from primary liver cancer in England and Wales 1975-92: influence of oral contraceptives. Br J Cancer 1995; 72:800-803.
27. Ribes J, Cleries R, Borras J, Galceran J, Bosch FX. Time trends in incidence and mortality for chronic liver disease and liver cancer in the interval 1980-1997 in Catalonia, Spain. Eur J Gastroenterol Hepatol 2004; 16:865-872.
28. La VC, Lucchini F, Franceschi S, Negri E, Levi F. Trends in mortality from primary liver cancer in Europe. Eur J Cancer 2000; 36:909-915.
29. Faivre J, Forman D, Esteve J, Obradovic M, Sant M. Survival of patients with primary liver cancer, pancreatic cancer and biliary tract cancer in Europe. EUROCARE Working Group. Eur J Cancer 1998; 34:2184-2190.
30. Levi F, Lucchini F, Negri E, Boyle P, La VC. Cancer mortality in Europe, 1995-1999, and an overview of trends since 1960. Int J Cancer 2004; 110:155-169.
31. Khan SA, Taylor-Robinson SD, Toledano MB, Beck A, Elliott P, Thomas HC. Changing international trends in mortality rates for liver, biliary and pancreatic tumours. J Hepatol 2002; 37:806-813.
32. Pouessel D, Thezenas S, Culine S, Becht C, Senesse P, Ychou M. Hepatic metastases from carcinomas of unknown primary site. Gastroenterol Clin Biol 2005; 29:1224-1232.
33. Hogan BA, Thornton FJ, Brannigan M, Browne TJ, Pender S, O'Kelly P, et al. Hepatic metastases from an unknown primary neoplasm (UPN): survival, prognostic indicators and value of extensive investigations. Clin Radiol 2002; 57:1073-1077.